1. Home
  2. AIMD vs DOMH Comparison

AIMD vs DOMH Comparison

Compare AIMD & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIMD

Ainos Inc.

HOLD

Current Price

$2.12

Market Cap

10.9M

Sector

Health Care

ML Signal

HOLD

Logo Dominari Holdings Inc.

DOMH

Dominari Holdings Inc.

HOLD

Current Price

$4.56

Market Cap

69.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIMD
DOMH
Founded
1984
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
69.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AIMD
DOMH
Price
$2.12
$4.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.6K
312.6K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
14.71%
EPS Growth
N/A
N/A
EPS
N/A
9.19
Revenue
$113,037.00
$99,588,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.49
Revenue Growth
178.19
691.07
52 Week Low
$1.78
$0.83
52 Week High
$5.00
$13.58

Technical Indicators

Market Signals
Indicator
AIMD
DOMH
Relative Strength Index (RSI) 41.63 49.59
Support Level $1.94 $3.73
Resistance Level $2.29 $4.68
Average True Range (ATR) 0.17 0.29
MACD 0.03 0.08
Stochastic Oscillator 27.72 60.89

Price Performance

Historical Comparison
AIMD
DOMH

About AIMD Ainos Inc.

Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.

Share on Social Networks: